Trinity Biosystems, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Trinity Biosystems, Inc. - overview
Established
2002
Location
Menlo Park, CA, US
Primary Industry
Biotechnology
About
Founded in 2002, Trinity Biosystems, Inc. engages in the development and formulation of oral therapeutic proteins. It involves in developing vaccines in the areas of respiratory, digestive, and sexually transmitted diseases.
Current Investors
Sanderling Ventures, Tenex Greenhouse Ventures, SR One
Primary Industry
Biotechnology
Sub Industries
Epidemiology, Biomaterials
Company Stage
Ceased Operations
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.